Wird geladen...
Parkinson's Disease Therapeutics: New Developments and Challenges Since the Introduction of Levodopa
The demonstration that dopamine loss is the key pathological feature of Parkinson's disease (PD), and the subsequent introduction of levodopa have revolutionalized the field of PD therapeutics. This review will discuss the significant progress that has been made in the development of new pharma...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Nature Publishing Group
2012
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3238085/ https://ncbi.nlm.nih.gov/pubmed/21956442 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npp.2011.212 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|